Cartesian Therapeutics, Inc.
Ticker: RNAC
| Insider | Title |
|---|---|
| Ann K. Donohue | VP Finance |
| Aymeric Sallin | Director |
| Blaine Davis | Chief Financial Officer |
| Carrie Smith Cox | Director |
| Carsten Brunn | President and CEO, Director |
| Christopher M Jewell | Chief Scientific Officer |
| Elizabeth Hoge | 10% or greater ownership |
| Emily English | SVP, Head of Manufacturing |
| Goran Ando | Director |
| Kemal Malik | Director |
| Kevin Tan | Chief Financial Officer |
| Lloyd P. Johnston | Chief Operations Officer |
| Metin Kurtoglu | Chief Technology Officer |
| Michael Singer | Director |
| Milos Miljkovic | Chief Medical Officer |
| Murat Kalayoglu | Director, 10% or greater ownership |
| Nishan M Desilva | Director |
| One Eight Three Four Irrevocable Trust Seven | 10% or greater ownership |
| Patrick J Zenner | Director |
| Peter G Traber | Director |
| Scott Dunseth Myers | Director |
| Takashi Kei Kishimoto | Chief Scientific Officer |
| Timothy A Springer | Director, 10% or greater ownership |
| Timothy C Barabe | Director |